Senate Dems Plan To Force Budget Vote On Medicare Rx Price Negotiating By HHS
This article was originally published in The Pink Sheet Daily
Non-binding amendment would reference expected savings from negotiating for single-source drugs with no competition. Sen. Wyden had sought clarification on the issue from the Congressional Budget Office.
You may also be interested in...
CMS is declining to predict whether the four retiree health coverage options available to employers and outlined in a Medicare proposed rule issued July 26 will be sufficient to stem the tide of employer dropouts
Price setting or negotiations could allow for seamless Medicare Rx coverage without overall cost increase, according to an analysis by Johns Hopkins' Anderson; trade-off of 45% price reduction would be limited research and development.
Sponsors' use of pharmacy passive acceptance agreements could be contributing to inaccurate participation data on Medicare Web site, House Democrats say. AdvancePCS, Anthem and Medco among firms in question.